Select Page

Oncology Articles

Scientists inject one tumor and watch cancer vanish across the body

### Summary: Engineered CD40 Agonist Antibody Induces Systemic Tumor Regression in Phase 1 Trial A groundbreaking phase 1 clinical trial has demonstrated the potential of an engineered CD40 agonist antibody, 2141-V11, to elicit robust systemic anti-tumor responses with minimal toxicity. Developed by researchers at Rockefeller University, this modified antibody addresses longstanding limitations of traditional CD40…

Read More

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Your Title Goes Here